Mutual Of America Capital Management LLC Cara Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$8.24 - $12.56 $15,384 - $23,449	1,867 Added 26.26%	8,978 $84,000
Q2 2022 Aug 10, 2022	BUY	$7.45 - $13.84 $8,031 - $14,919	1,078 Added 17.87%	7,111 $65,000
Q1 2022 May 02, 2022	BUY	$9.94 - $12.65 $2,614 - $3,326	263 Added 4.56%	6,033 $73,000
Q4 2021 Feb 03, 2022	BUY	$11.99 - $18.14 $1,906 - $2,884	159 Added 2.83%	5,770 $70,000
Q3 2021 Nov 10, 2021	SELL	$11.55 - $16.06 $5,878 - $8,174	-509 Reduced 8.32%	5,611 $87,000
Q2 2021 Aug 06, 2021	BUY	$12.38 - $29.19 $75,765 - $178,642	6,120 New	6,120 $87,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.